Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Complicated Vascular Anomalies
NCT03583307Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sirolimus in Vascular anomalies, sponsored by West China Hospital of Sichuan University. Primary endpoints: Volumetric changes in complicated vascular anomalies to sirolimus at 12 months and The changes in the patient's symptoms and/or complications at 12 months. Started Jun 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
Vascular anomalies
Beyond the preview
Go deeper on NCT03583307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03583307.